Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Mupirocin may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for
Bactroban 2% Nasal Ointment (called 'Bactroban' in this leaflet) contains the active substance mupirocin calcium. Bactroban is an antibiotic ointment. It is used: • • •
2
to kill a group of bacteria in the nose called 'Staphylococci' this group includes MRSA (Methicillin Resistant Staphylococcus aureus) this ointment is for use in your nose only.
e Bactroban
Do not use Bactroban:
Pregnancy and breast-feeding
1
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. Driving and using machines It is unlikely that Bactroban will affect your ability to drive or operate machinery.
3
Bactroban
Always use this medicine exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. Using this medicine You usually apply Bactroban to your nose two to three times a day. 1 Wash and dry your hands. 2 Place a small amount of Bactroban, about the size of a match head, on your little finger. 3 Apply this to the inside of one nostril. 4 Repeat steps 2 and 3 for your other nostril. 5 Press the sides of your nose together to spread the ointment around the nostril. 6 Replace the cap on the tube and wash your hands. A cotton bud can be used instead of your little finger to apply the ointment, particularly in infants or the very ill. How long should you use Bactroban for? Use Bactroban for as long as your doctor has told you. If you are not sure, ask your doctor, nurse or pharmacist. The bacteria are normally cleared from your nose within 5 to 7 days of starting treatment. If you swallow any Bactroban If you swallow any of the ointment, speak to your doctor, nurse or pharmacist for advice. If you forget to use Bactroban
4
Like all medicines, this medicine can cause side effects, although not everybody gets them. Conditions to look out for Severe skin reactions or allergies: These are very rare in people using Bactroban. Signs include:
•
tell your doctor as soon as possible.
On rare occasions, medicines like Bactroban can cause inflammation of the colon (large intestine), causing diarrhoea, usually with blood and mucus, stomach pain, fever (pseudomembranous colitis). ➔ Tell your doctor as soon as possible if you get any of these symptoms. The following side effects may happen with this medicine: Uncommon (may affect up to 1 in 100 people)
5 • • •
Bactroban Keep this medicine out of the sight and reach of children. Do not store above 25°C. Do not use Bactroban after the expiry date which is stated on the tube or carton after (EXP). The expiry date refers to the last day of that month. Bactroban is an off-white smooth ointment. Do not use it if it looks different to normal. Do not throw away medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
• •
6
What Bactroban contains
Marketing Authorisation Holder and Manufacturer Marketing Authorisation holder: Beecham Group plc 79 New Oxford Street London
WC1A 1DG United Kingdom
Manufacturer: Glaxo Wellcome Operations Harmire Road Barnard Castle Co Durham DL12 8DT This leaflet was last revised in November 2024. Other formats: To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge:
0800 198 5000 (UK Only) Please be ready to give the following information: Product Name Reference number
Bactroban 2% Nasal Ointment 00038/0347
This is a service provided by the Royal National Institute of Blind People. Trade marks are owned by or licensed to the GSK group of companies. © 2024 GSK group of companies or its licensor
Bactroban Nasal Ointment 2% comes as ointment. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Bactroban Nasal Ointment 2% is mupirocin.
Medicines with the same active substance, strength and form include: Bactroban Ointment 2%, Mupirocin 2% w/w Ointment, Mupirocin Ointment 2%. They are interchangeable only if your prescriber or pharmacist says so.
This leaflet reproduces the patient information leaflet approved for Bactroban Nasal Ointment 2%, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
The elimination of nasal carriage of staphylococci, including methicillin resistant Staphylococcus aureus (MRSA).
Posology
Adults (including the elderly) and children:
Bactroban Nasal Ointment should be applied to the anterior nares two to three times a day as follows:
A small amount of the ointment about the size of a match head is placed on the little finger and applied to the inside of each nostril. The nostrils are closed by pressing the sides of the nose together; this will spread the ointment throughout the nares. A cotton bud may be used instead of the little finger for the application in particular to infants or patients who are very ill.
Nasal carriage should normally clear within 5-7 days of commencing treatment.
Method of administration
Topical.
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Should a possible sensitisation reaction or severe local irritation occur with the use of Bactroban Nasal Ointment, treatment should be discontinued, the product should be wiped away and appropriate therapy instituted.
As with other antibacterial products, prolonged use may result in overgrowth of non-susceptible organisms.
Pseudomembranous colitis has been reported with the use of antibiotics and may range in severity from mild to life-threatening. Therefore, it is important to consider its diagnosis in patients who develop diarrhoea during or after antibiotic use. Although this is less likely to occur with topically applied mupirocin, if prolonged or significant diarrhoea occurs or the patient experiences abdominal cramps, treatment should be discontinued immediately and the patient investigated further.
This mupirocin nasal ointment formulation is not suitable for ophthalmic use.
Avoid contact with the eyes. If contaminated, the eyes should be thoroughly irrigated with water until the ointment residues have been removed.
No drug interactions have been identified
Pregnancy
Reproduction studies on Bactroban in animals have revealed no evidence of harm to the foetus (see section 5.3). As there is no clinical experience on its use during pregnancy, Bactroban should only be used in pregnancy when the potential benefits outweigh the possible risks of treatment.
Breast-feeding
There is no information on the excretion of Bactroban in milk.
Fertility
There are no data on the effects of mupirocin on human fertility. Studies in rats showed no effects on fertility (see section 5.3).
No adverse effects on the ability to drive or operate machinery have been identified.
Adverse reactions are listed below by system organ class and frequency. Frequencies are defined as: very common (≥1/10), common (≥1/100, <1/10), uncommon (≥1/1000, <1/100), rare (≥1/10,000, <1/1000), very rare (<1/10,000), including isolated reports.
Uncommon adverse reactions were determined from pooled safety data from a clinical trial population of 422 treated patients encompassing 12 clinical studies. Very rare adverse reactions were primarily determined from post-marketing experience data and therefore refer to reporting rate rather than true frequency.
Immune system disorders
Very rare:
Cutaneous hypersensitivity reactions. Systemic allergic reactions including anaphylaxis, generalised rash, urticaria and angioedema.
Respiratory, thoracic and mediastinal disorders
Uncommon:
Nasal mucosa reactions.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard
Symptoms and signs
There is currently limited experience with overdosage of mupirocin.
Treatment
There is no specific treatment for an overdose of mupirocin. In the event of overdose, the patient should be treated supportively with appropriate monitoring as necessary. Further management should be as clinically indicated or as recommended by the national poisons centre, where available.
Ask anything about Bactroban Nasal Ointment 2%. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.